Condition 101 About Non-Langerhans-Cell Histiocytosis

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Non-Langerhans-Cell Histiocytosis

JH
Elite
J J. Haroche
Paris, FR
LD
Elite
Lorenzo Dagna
Milan, IT
GC
Elite
Giulio G. Cavalli
Milan, IT
FA
Elite
Fleur Aubart-Cohen
Paris, FR

Latest Advances On Non-Langerhans-Cell Histiocytosis

  • Condition: Subcutaneous Panniculitis-Like T-Cell Lymphoma with Hemophagocytic Lymphohistiocytosis Mimicking Cellulitis
  • Journal: The American journal of case reports
  • Treatment Used: Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone, and Etoposide (ECHOP) Chemotherapy
  • Number of Patients: 1
  • Published —
This case report describes a patient with a rare form of subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic lymphohistiocytosis that mimicked cellulitis.
  • Condition: Erdheim-Chester Disease (ECD)
  • Journal: The Canadian journal of urology
  • Treatment Used: Percutaneous Nephrolithotomy
  • Number of Patients: 1
  • Published —
This case report describes a patient with Erdheim-Chester disease (ECD), a rare systemic disorder, who developed kidney stones treated with percutaneous nephrolithotomy.

Clinical Trials For Non-Langerhans-Cell Histiocytosis

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug
  • Participants: 62
  • Start Date: February 2021
Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 140
  • Start Date: September 30, 2020
Complement Activation in the Lysosomal Storage Disorders